RxDoctor Payments Data

Joseph Owen, MD

Clinical Cardiac Electrophysiology · Jackson, MSNPI 1578753943

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,073 of the $7,824 with a category attached, or 77.6%. It is spread thinly across 43 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations.

$7,824in general payments, 2019–2025

Across 309 payments — averaging $25.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Medical Device Business Services, Inc.$705
  • Johnson & Johnson$696
  • Medtronic$627
  • Novartis$593
  • Pfizer$394
  • plus $3K from 37 others

What the payments were for

  • Travel & lodging$1,73722%
  • Food & beverage$6,07378%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few clinical cardiac electrophysiology providers in Mississippito place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$265,475
Medicare patients
878
Services billed
8,433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban67$68,894
EntrestoSacubitril/Valsartan17$11,078
XareltoRivaroxaban14$8,766
Dofetilide14$6,001
Flecainide Acetate34$1,575
Metoprolol Succinate81$1,191
Amiodarone Hcl46$1,120
Atorvastatin Calcium12$45
Metoprolol Tartrate13$41
Furosemide19$35

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$394$68,89467 claims
NovartisEntresto$593$11,07817 claims
Johnson & JohnsonXarelto$696$8,76614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few clinical cardiac electrophysiology providers in Mississippion file to place this against a meaningful peer group, so we don't.

Other clinical cardiac electrophysiology in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →